Suppr超能文献

高血压患病率与控制情况的全球差异:来自90个国家基于人群研究的系统分析

Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries.

作者信息

Mills Katherine T, Bundy Joshua D, Kelly Tanika N, Reed Jennifer E, Kearney Patricia M, Reynolds Kristi, Chen Jing, He Jiang

机构信息

From Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA (K.T.M., J.D.B., T.N.K., J.E.R., J.C., J.H.); Department of Epidemiology and Public Health, University College Cork, Cork, Ireland (P.M.K.); Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA (K.R.); and Department of Medicine, Tulane University School of Medicine, New Orleans, LA (J.C., J.H.).

出版信息

Circulation. 2016 Aug 9;134(6):441-50. doi: 10.1161/CIRCULATIONAHA.115.018912.

Abstract

BACKGROUND

Hypertension is the leading preventable cause of premature death worldwide. We examined global disparities of hypertension prevalence, awareness, treatment, and control in 2010 and compared secular changes from 2000 to 2010.

METHODS

We searched MEDLINE from 1995 through 2014 and supplemented with manual searches of retrieved article references. We included 135 population-based studies of 968 419 adults from 90 countries. Sex- and age-specific hypertension prevalences from each country were applied to population data to calculate regional and global numbers of hypertensive adults. Proportions of awareness, treatment, and control from each country were applied to hypertensive populations to obtain regional and global estimates.

RESULTS

In 2010, 31.1% (95% confidence interval, 30.0%-32.2%) of the world's adults had hypertension; 28.5% (27.3%-29.7%) in high-income countries and 31.5% (30.2%-32.9%) in low- and middle-income countries. An estimated 1.39 (1.34-1.44) billion people had hypertension in 2010: 349 (337-361) million in high-income countries and 1.04 (0.99-1.09) billion in low- and middle-income countries. From 2000 to 2010, the age-standardized prevalence of hypertension decreased by 2.6% in high-income countries, but increased by 7.7% in low- and middle-income countries. During the same period, the proportions of awareness (58.2% versus 67.0%), treatment (44.5% versus 55.6%), and control (17.9% versus 28.4%) increased substantially in high-income countries, whereas awareness (32.3% versus 37.9%) and treatment (24.9% versus 29.0%) increased less, and control (8.4% versus 7.7%) even slightly decreased in low- and middle-income countries.

CONCLUSIONS

Global hypertension disparities are large and increasing. Collaborative efforts are urgently needed to combat the emerging hypertension burden in low- and middle-income countries.

摘要

背景

高血压是全球可预防的过早死亡的主要原因。我们研究了2010年全球高血压患病率、知晓率、治疗率和控制率的差异,并比较了2000年至2010年的长期变化。

方法

我们检索了1995年至2014年的MEDLINE,并通过人工检索所检索文章的参考文献进行补充。我们纳入了来自90个国家的968419名成年人的135项基于人群的研究。将每个国家按性别和年龄划分的高血压患病率应用于人口数据,以计算区域和全球高血压成年人的数量。将每个国家的知晓率、治疗率和控制率应用于高血压人群,以获得区域和全球估计数。

结果

2010年,全球31.1%(95%置信区间,30.0%-32.2%)的成年人患有高血压;高收入国家为28.5%(27.3%-29.7%),低收入和中等收入国家为31.5%(30.2%-32.9%)。2010年估计有13.9亿(13.4-14.4亿)人患有高血压:高收入国家为3.49亿(3.37-3.61亿),低收入和中等收入国家为10.4亿(9.9-10.9亿)。从2000年到2010年,高收入国家年龄标准化的高血压患病率下降了2.6%,而低收入和中等收入国家则上升了7.7%。在同一时期,高收入国家的知晓率(58.2%对67.0%)、治疗率(44.5%对55.6%)和控制率(17.9%对28.4%)大幅上升,而低收入和中等收入国家的知晓率(32.3%对37.9%)和治疗率(24.9%对29.0%)上升较少,控制率(8.4%对7.7%)甚至略有下降。

结论

全球高血压差异巨大且在不断扩大。迫切需要开展合作努力,以应对低收入和中等收入国家新出现的高血压负担。

相似文献

3
Expanding global access to radiotherapy.
Lancet Oncol. 2015 Sep;16(10):1153-86. doi: 10.1016/S1470-2045(15)00222-3.
4
A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010.
Kidney Int. 2015 Nov;88(5):950-7. doi: 10.1038/ki.2015.230. Epub 2015 Jul 29.
7
Global cardiac surgery: Access to cardiac surgical care around the world.
J Thorac Cardiovasc Surg. 2020 Mar;159(3):987-996.e6. doi: 10.1016/j.jtcvs.2019.04.039. Epub 2019 Apr 26.
10
Global burden of hypertension: analysis of worldwide data.
Lancet. 2005;365(9455):217-23. doi: 10.1016/S0140-6736(05)17741-1.

引用本文的文献

5
Screening for endocrine hypertension in China: protocol for a multicentre prospective cohort study.
BMJ Open. 2025 Aug 31;15(8):e098446. doi: 10.1136/bmjopen-2024-098446.
8
Hypertension Cascade Across Three Healthcare Systems and in Relation to the Level of Implementation of the Integrated Care Package.
Int J Integr Care. 2025 Aug 22;25(3):22. doi: 10.5334/ijic.8921. eCollection 2025 Jul-Sep.
9
Burden of hypertension and type 2 diabetes in Tamale Metropolis: a case study of Tamale teaching hospital.
BMC Public Health. 2025 Aug 26;25(1):2927. doi: 10.1186/s12889-025-23979-4.

本文引用的文献

1
A Randomized Trial of Intensive versus Standard Blood-Pressure Control.
N Engl J Med. 2015 Nov 26;373(22):2103-16. doi: 10.1056/NEJMoa1511939. Epub 2015 Nov 9.
3
The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling Study.
PLoS Med. 2015 Aug 4;12(8):e1001860. doi: 10.1371/journal.pmed.1001860. eCollection 2015 Aug.
4
Cost-effectiveness of hypertension therapy according to 2014 guidelines.
N Engl J Med. 2015 Jan 29;372(5):447-55. doi: 10.1056/NEJMsa1406751.
8
Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration.
Lancet. 2013 Feb 23;381(9867):680-9. doi: 10.1016/S0140-6736(12)62128-X. Epub 2013 Feb 12.
9
Embedding non-communicable diseases in the post-2015 development agenda.
Lancet. 2013 Feb 16;381(9866):566-74. doi: 10.1016/S0140-6736(12)61806-6. Epub 2013 Feb 12.
10
Prevalence, risk factors and awareness of hypertension in India: a systematic review.
J Hum Hypertens. 2013 May;27(5):281-7. doi: 10.1038/jhh.2012.33. Epub 2012 Sep 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验